Cheng H, Curtis A, Fellingham C, Hancox J
Physiol Rep. 2016; 4(11).
PMID: 27288059
PMC: 4908495.
DOI: 10.14814/phy2.12819.
Choisy S, Cheng H, Orchard C, James A, Hancox J
Physiol Rep. 2015; 3(11).
PMID: 26607172
PMC: 4673654.
DOI: 10.14814/phy2.12633.
Yuill K, Al Kury L, Howarth F
Physiol Rep. 2015; 3(11).
PMID: 26603460
PMC: 4673653.
DOI: 10.14814/phy2.12632.
Nisbet A, Burton F, Walker N, Craig M, Cheng H, Hancox J
Front Physiol. 2014; 5:233.
PMID: 25009505
PMC: 4070392.
DOI: 10.3389/fphys.2014.00233.
Groenke S, Larson E, Alber S, Zhang R, Lamp S, Ren X
PLoS One. 2013; 8(11):e81633.
PMID: 24278453
PMC: 3836769.
DOI: 10.1371/journal.pone.0081633.
The effect of verapamil on halothane-epinephrine or digitalis-induced ventricular dysrhythmias in dogs.
Yoshizawa Y, Shimizu R, Kasuda H, Akazawa S, Nemoto K, Inoue S
J Anesth. 1988; 2(1):28-35.
PMID: 15235830
DOI: 10.1007/s0054080020028.
Actions of the digitalis analogue strophanthidin on action potentials and L-type calcium current in single cells isolated from the rabbit atrioventricular node.
Hancox J, Levi A
Br J Pharmacol. 1996; 118(6):1447-54.
PMID: 8832071
PMC: 1909687.
DOI: 10.1111/j.1476-5381.1996.tb15559.x.
Periodic paralysis and ventricular tachycardia: possible role of calcium channel blockers.
Ebeid M, Baquero J, Gelband H
Pediatr Cardiol. 1996; 17(1):31-4.
PMID: 8778698
DOI: 10.1007/BF02505808.
Verapamil and supraventricular tachyarrhythmias: beneficial effect in patients with chronic pulmonary disease.
Rabkin S, Tomlinson C, CORBETT B, Cuddy T
Can Med Assoc J. 1980; 122(1):64-8.
PMID: 7363198
PMC: 1801604.
Evidence for adenosine mediation of atrioventricular block in the ischemic canine myocardium.
Belardinelli L, Mattos E, BERNE R
J Clin Invest. 1981; 68(1):195-205.
PMID: 7251860
PMC: 370787.
DOI: 10.1172/jci110235.
Differential effects of organic slow inward current inhibitors, verapamil and nifedipine, on rate of atrioventricular rhythm and supraventricular tachycardia in the canine isolated, blood-perfused AV node preparation.
Motomura S, Taira N
Naunyn Schmiedebergs Arch Pharmacol. 1981; 315(3):241-8.
PMID: 7219573
DOI: 10.1007/BF00499841.
Electrophysiological effects of the salicylates on isolated atrial muscle of the rabbit.
Riccioppo Neto F
Br J Pharmacol. 1982; 77(2):285-92.
PMID: 7139189
PMC: 2044608.
DOI: 10.1111/j.1476-5381.1982.tb09297.x.
Role of calcium antagonists in cardiovascular therapy.
Dargie H, Rowland E, Krikler D
Br Heart J. 1981; 46(1):8-16.
PMID: 7023517
PMC: 482595.
DOI: 10.1136/hrt.46.1.8.
Antihypertensive and renal effects of orally administered verapamil.
Leonetti G, Sala C, Bianchini C, Terzoli L, Zanchetti A
Eur J Clin Pharmacol. 1980; 18(5):375-82.
PMID: 7002568
DOI: 10.1007/BF00636788.
Effects of verapamil on ventricular tachycardias possibly caused by reentry, automaticity, and triggered activity.
Sung R, Shapiro W, Shen E, Morady F, Davis J
J Clin Invest. 1983; 72(1):350-60.
PMID: 6874951
PMC: 1129190.
DOI: 10.1172/jci110975.
Interaction between calcium and slow channel blocking drugs on atrial rate.
Camilion de Hurtado M, Cingolani H
Naunyn Schmiedebergs Arch Pharmacol. 1983; 322(1):65-71.
PMID: 6843691
DOI: 10.1007/BF00649354.
Calcium antagonists. Clinical use in the treatment of arrhythmias.
Singh B, Nademanee K, Baky S
Drugs. 1983; 25(2):125-53.
PMID: 6339197
DOI: 10.2165/00003495-198325020-00003.
Calcium antagonists: definition and mode of action.
NAYLER W, Poole-Wilson P
Basic Res Cardiol. 1981; 76(1):1-15.
PMID: 6112981
DOI: 10.1007/BF01908159.
[Electrophysiological classification of newer antiarrhythmic drugs (author's transl)].
Schmitz W
Klin Wochenschr. 1980; 58(18):907-18.
PMID: 6110804
DOI: 10.1007/BF01477048.
Diltiazem. A review of its pharmacological properties and therapeutic efficacy.
Chaffman M, Brogden R
Drugs. 1985; 29(5):387-454.
PMID: 3891302
DOI: 10.2165/00003495-198529050-00001.
